Literature DB >> 27364057

Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.

Freddy Del-Carpio Munoz, Xiaoxi Yao, Neena S Abraham, M Fernanda Bellolio, Alejandro A Rabinstein, Samuel J Asirvatham, Robert D McBane, Bernard J Gersh, Nilay D Shah, Peter A Noseworthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27364057     DOI： 10.1016/j.jacc.2016.04.031

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Clinical Discussions in Antithrombotic Therapy Management in Patients With Atrial Fibrillation: A Delphi Consensus Panel.

Authors:  Nicola Mumoli; Claudia Amellone; Gianfranco Antonelli; Giuseppe Augello; Cosima Cloro; Alberto D'Alleva; Leonardo Di Ascenzo; Egidio Imbalzano; Renato Masala; Graziano Riccioni; Emanuele Romeo; Luca Rossi; Giosuè Santoro; Edoardo Sciatti; Antonio Tondo; Elisabetta Toso; Elio Venturini; Enrico Vizzardi; Giosuè Mascioli
Journal:  CJC Open       Date:  2020-07-23

Review 2.  Necessity of Antiaggregation and Anticoagulation and Its Prognostic Impact: A Cardiologist's View.

Authors:  Ulrich Hink; Thomas Voigtländer
Journal:  Visc Med       Date:  2020-07-21

3.  Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.

Authors:  Ophelia Yin; Tarundeep Kakkar; Anil Duggal; Masakatsu Kotsuma; Minggao Shi; Hans Lanz; Michael A Grosso
Journal:  Clin Pharmacol Drug Dev       Date:  2021-12-07

Review 4.  Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease.

Authors:  Martin van Zyl; Hafez M Abdullah; Peter A Noseworthy; Konstantinos C Siontis
Journal:  J Clin Med       Date:  2020-01-02       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.